EconomyEXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks
A major Novartis shareholder is urging a shake-up of the Swiss drugmaker’s board to strengthen corporate governance after the company’s shares suffered their biggest-ever fall this week following two consecutive trial setbacks.
EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks
